ArticleMolecular therapy. Nucleic acids2023

CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2.

Javier Poyatos-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.